Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 700 of 715 entries
View as:

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Phase: N/A Priority: Normal
NCT ID: NCT00342940 Org: User:
Start: 10/31/06 End: - Due: -

Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over

Phase: N/A Priority: Normal
NCT ID: NCT00170768 Org: User:
Start: 02/28/05 End: 05/31/05 Due: 05/31/06

Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Phase: N/A Priority: Normal
NCT ID: NCT00290771 Org: User:
Start: 02/28/06 End: 08/31/08 Due: 08/31/09

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00262236 Org: User:
Start: 11/30/05 End: 08/31/06 Due: 08/31/07

Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00434733 Org: User:
Start: 01/31/07 End: - Due: -

Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00129831 Org: User:
Start: 09/30/04 End: 09/30/05 Due: 09/30/06

A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT00463242 Org: User:
Start: 03/31/07 End: - Due: -

Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain

Phase: N/A Priority: Normal
NCT ID: NCT01666197 Org: User:
Start: 08/31/12 End: 01/31/13 Due: 01/31/14

Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol

Phase: N/A Priority: Normal
NCT ID: NCT00422552 Org: User:
Start: 09/30/06 End: - Due: -

A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00230074 Org: User:
Start: 11/30/04 End: 02/28/05 Due: 02/28/06

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00787605 Org: User:
Start: 11/30/08 End: 01/31/10 Due: 01/31/11

Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00416468 Org: User:
Start: 11/30/06 End: - Due: -

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00413049 Org: User:
Start: 01/31/07 End: 11/30/07 Due: 11/30/08

Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00557440 Org: User:
Start: 11/30/07 End: 04/30/08 Due: 04/30/09

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00504959 Org: User:
Start: 07/31/07 End: 01/31/10 Due: 01/31/11

Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

Phase: N/A Priority: Normal
NCT ID: NCT00170781 Org: User:
Start: 06/30/05 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00619905 Org: User:
Start: 12/31/03 End: 08/31/05 Due: 08/31/06

Efficacy and Safety of Lumiracoxib

Phase: N/A Priority: Normal
NCT ID: NCT00267215 Org: User:
Start: 11/30/00 End: - Due: -

A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01220115 Org: User:
Start: 01/31/10 End: 09/30/14 Due: 09/30/15

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT00616811 Org: User:
Start: 01/31/08 End: 10/31/10 Due: 10/31/11

Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection

Phase: N/A Priority: Normal
NCT ID: NCT00098046 Org: User:
Start: 07/31/05 End: 07/31/07 Due: 07/31/08

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06604897 Org: User:
Start: 01/31/23 End: 03/31/25 Due: 03/31/26

Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol

Phase: N/A Priority: Normal
NCT ID: NCT00531050 Org: User:
Start: 08/31/07 End: 06/30/08 Due: 06/30/09

Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants

Phase: N/A Priority: Normal
NCT ID: NCT00238940 Org: User:
Start: 02/28/03 End: 09/30/05 Due: 09/30/06

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT00537082 Org: User:
Start: 09/30/07 End: - Due: -